Comprehensive Tumor Profiling
The Caris Molecular Intelligence® comprehensive tumor profiling approach to assess DNA, RNA and proteins reveals a molecular blueprint to guide more precise and individualized treatment decisions from about 60+ FDA-approved therapies.
Whole Exome Sequencing
(Mutations, Indels & Copy Number Alterations)
Whole Transcriptome Sequencing
(Fusions & Variant Transcripts)
The information below details the biomarkers analyzed by technology for the tumor type submitted. Before ordering testing services, please refer to this profile menu to view the most-up-to date listing of biomarkers that will be performed. Tests may vary if samples with insufficient tissue are submitted.
Next-Generation Sequencing (NGS)
Whole Transcriptome Sequencing (WTS)
Select tumor type to see specific tests to be performed.
Caris applies the appropriate tumor-specific customizations standard with every MI Profile test order.